专题：Amyloidosis: Diagnosis, Treatment, Outcomes

This cluster of papers focuses on the molecular mechanisms, diagnosis, treatment, and prognosis of amyloidosis, with a particular emphasis on transthyretin-related cardiac and familial amyloid polyneuropathy. It covers topics such as RNAi therapy, cardiovascular magnetic resonance, and immunoglobulin light chain involvement.
最新文献
Statin-related rhabdomyolysis in the context of drug interaction with tafamidis

article Full Text OpenAlex

Machine Learning to Automatically Differentiate Hypertrophic Cardiomyopathy, Cardiac Light Chain, and Cardiac Transthyretin Amyloidosis: A Multicenter CMR Study

article Full Text OpenAlex

Epidemiology and clinical presentation of kidney amyloidosis have changed over the past three decades: a nationwide population-based study

article Full Text OpenAlex

Sphingolipid imbalance aggravates tau pathology by endomembrane rigidification and rupture

preprint Full Text OpenAlex

Restrictive Cardiomyopathy and Coronary Artery Bypass Grafting

article Full Text OpenAlex

Clonal plasma cell features in light-chain amyloidosis are associated with depth and timing of cardiac response independent of hematologic response

article Full Text OpenAlex

Early Increase in Serum Transthyretin by Acoramidis Independently Predicts Improved Survival in TTR Amyloid Cardiomyopathy

article Full Text OpenAlex

Experimental methods for studying amyloid cross‐interactions

review Full Text OpenAlex

Vutrisiran Improves Survival and Reduces Cardiovascular Events in ATTR Amyloid Cardiomyopathy

article Full Text OpenAlex

Treatment with vutrisiran in people with transthyretin amyloidosis with cardiomyopathy: a plain language summary

article Full Text OpenAlex

近5年高被引文献
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis

article Full Text OpenAlex 1234 FWCI85.496

Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases

article Full Text OpenAlex 858 FWCI56.479

Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology

article Full Text OpenAlex 510 FWCI60.363

Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis

article Full Text OpenAlex 472 FWCI31.896

2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis

article Full Text OpenAlex 304 FWCI53.097

Performance of plasma phosphorylated tau 181 and 217 in the community

article Full Text OpenAlex 294 FWCI61.103

Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

article Full Text OpenAlex 281 FWCI18.904

The expanding amyloid family: Structure, stability, function, and pathogenesis

review Full Text OpenAlex 280 FWCI8.84

Amyloid nomenclature 2022: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee

article Full Text OpenAlex 251 FWCI25.251

Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial

article Full Text OpenAlex 247 FWCI24.724